J. Bestard

Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy.

M. Zaccolo, F. Muntoni, T. Pozzan, 2001, Human molecular genetics.

MP28: Reducing door-to-needle times across Alberta to 36 minutes

Eric E. Smith, M. Hill, N. Kamal, 2018 .

CRYPTOCOCCAL MENINGOENCEPHALITIS IN IMMUNOCOMPETENT PATIENTS: CHANGING TRENDS IN CANADA

Z. Siddiqi, J. Bestard, Jennifer A. Bestard, 2010, Neurology.

Dystrophin gene regulation in muscle

J. Bestard, Jennifer A. Bestard, 2000 .

An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

L. Korngut, C. Toth, J. Bestard, 2012, PAIN®.

An Open‐Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy

C. Toth, J. Bestard, Jennifer A. Bestard, 2011, Pain practice : the official journal of World Institute of Pain.

Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community Hospital

M. Hill, N. Kamal, T. Jeerakathil, 2018, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic.

L. Korngut, C. Toth, J. Bestard, 2011, Pain research & management.

Provincial Door-to-Needle Improvement Initiative Results in Improved Patient Outcomes Across an Entire Population

Eric E. Smith, A. Demchuk, M. Hill, 2020, Stroke.